Snowden Capital Advisors’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-29,116
| Closed | -$243K | – | 1131 |
|
|
2023
Q3 | $243K | Sell |
29,116
-2,537
| -8% | -$21.2K | 0.01% | 933 |
|
|
2023
Q2 | $421K | Buy |
31,653
+12
| +0% | +$160 | 0.02% | 812 |
|
|
2023
Q1 | $366K | Sell |
31,641
-30,910
| -49% | -$358K | 0.01% | 862 |
|
|
2022
Q4 | $512K | Sell |
62,551
-120
| -0.2% | -$982 | 0.02% | 699 |
|
|
2022
Q3 | $363K | Sell |
62,671
-9,902
| -14% | -$57.4K | 0.02% | 803 |
|
|
2022
Q2 | $320K | Sell |
72,573
-4,096
| -5% | -$18.1K | 0.01% | 831 |
|
|
2022
Q1 | $697K | Buy |
76,669
+12,867
| +20% | +$117K | 0.03% | 532 |
|
|
2021
Q4 | $1.31M | Sell |
63,802
-108,816
| -63% | -$2.23M | 0.07% | 295 |
|
|
2021
Q3 | $4.41M | Buy |
172,618
+2,314
| +1% | +$59.1K | 0.22% | 136 |
|
|
2021
Q2 | $5.96M | Buy |
170,304
+609
| +0.4% | +$21.3K | 0.3% | 83 |
|
|
2021
Q1 | $5.65M | Buy |
169,695
+32,087
| +23% | +$1.07M | 0.32% | 75 |
|
|
2020
Q4 | $3.57M | Buy |
137,608
+14,159
| +11% | +$367K | 0.24% | 133 |
|
|
2020
Q3 | $1.22M | Buy |
+123,449
| New | +$1.22M | 0.1% | 245 |
|